Skip to main content

Table 1 Main laboratory data and characteristics of the studied population

From: Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?

 

Diagnosis

 

CHC n 36

FL n 45

NASH n 42

 

Gender

Mean

SD

Gender

Mean

SD

Gender

Mean

SD

Age

 

44.5

10.0

 

42.3

9.1

 

40.4

10.5

TGF-β1 ng/mL*

 

87.5

39.5

 

129.1

45.4

 

116.8

42.2

CRP

    

0.8

0.4

 

0.9

0.4

ALT U/L#

 

72.7

25.6

 

49.2

17.8

 

54.3

21.8

Ferritin ng/mL

17 F

203.6

86.5

21 F

232.3

117.4

19 F

279.8

150.3

Ferritin ng/mL

19 M

396.4

153.5

24 M

381.5

137.2

23 M

357.2

132.3

Waist Circumference (cm)

   

21 F

98

6.1

19 F

100

4.7

Waist Circumference (cm)

   

24 M

105

6.3

23 M

108

7.7

HOMA

    

3.2

1.4

 

3.4

1.5

  

Median

Range

 

Median

Range

 

Median

Range

BMI‡

 

26

22–30

 

29

27–32

 

29

27–32

Fibrosis score

 

1

1–3

    

1

1–2

US steatosis Score

 

2

1–3

    

1

1–3

  1. CHC, chronic hepatitis C; FL, fatty liver; NASH, non-alcoholic steatohepatitis; ALT, alanine aminotransferase; CRP, C reactive protein; TGF-β1, transforming growth factor beta1; BMI, body mass index; HOMA, homeostasis model assessment-insulin resistance index.
  2. * P < 0.001, FL versus CHC and 0.008, NASH versus CHC patients; # P < 0.001, CHC versus FL and NASH patients; ‡ P < 0.001, CHC versus FL and NASH patients.
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us